Patents by Inventor Arsinur Burcoglu

Arsinur Burcoglu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7049430
    Abstract: Defibrotide including its nucleic acid components and the variants thereof can be used to treat various disease conditions. Such therapeutic compounds can also be administered in combination with other nucleic acids and peptides.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: May 23, 2006
    Inventor: Arsinur Burcoglu
  • Publication number: 20040138167
    Abstract: Defibrotide including its nucleic acid components and the variants thereof can be used to treat various disease conditions. Such therapeutic compounds can also be administered in combination with other nucleic acids and peptides.
    Type: Application
    Filed: February 2, 2004
    Publication date: July 15, 2004
    Inventor: Arsinur Burcoglu
  • Patent number: 6699985
    Abstract: Defibrotide including its nucleic acid components and the variants thereof can be used to treat various disease conditions. Such therapeutic compounds can also be administered in combination with other nucleic acids and peptides.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: March 2, 2004
    Inventor: Arsinur Burcoglu
  • Publication number: 20030013669
    Abstract: Defibrotide including its nucleic acid components and the variants thereof can be used to treat various disease conditions. Such therapeutic compounds can also be administered in combination with other nucleic acids and peptides.
    Type: Application
    Filed: January 5, 2001
    Publication date: January 16, 2003
    Inventor: Arsinur Burcoglu
  • Patent number: 5977083
    Abstract: Oligodeoxyribonucleotides, polydeoxyribonucleotides and derivatives thereof, such as defibrotide, are agents of genetic modulation at the levels of transcription, translation, secondary messengers and cellular signal transduction systems. Various disease states can be treated by modifying the dose of such agents in response to observed fluctuations (e.g., increase, decrease, appearance, disappearance) in normal, disease and repair markers.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 2, 1999
    Inventor: Arsinur Burcoglu
  • Patent number: 5624912
    Abstract: Oligonucleotides, polynucleotides and derivatives thereof, such as defibrotide, are agents of genetic modulation at the levels of transcription, translation, secondary messengers and cellular signal transduction systems. Such agents can be used to treat HIV infection. Preferably, treatment involves modifying the dose of such agents in response to observed fluctuations (e.g., increase, decrease, appearance, disappearance) in normal, disease and repair markers.
    Type: Grant
    Filed: January 24, 1994
    Date of Patent: April 29, 1997
    Inventors: Arsinur Burcoglu, Marc Wagner